An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol.

about

The Current State of Pharmacological Treatments for Cannabis Use Disorder and Withdrawal.Cannabinoid receptor-mediated disruption of sensory gating and neural oscillations: A translational study in rats and humans.

P2860

Q47963315-91C4DDBE-9EE9-42CD-B049-595594B7C4D0 Q52616960-B1110ABE-038A-49DA-BEB5-CEC669FA7049

P2860

An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol.

Item

http://www.wikidata.org/entity/Q39431492

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol.

@en

An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol.

@nl

type

Item

label

An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol.

@en

An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol.

@nl

prefLabel

An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol.

@en

An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol.

@nl

P1476

An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol.

@en

P2093

Patricia H Reggio

http://www.w3.org/2001/XMLSchema#string

P2860

The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo

Peripheral cannabinoid receptor, CB2, regulates bone mass.

Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L

Evidence that the plant cannabinoid cannabigerol is a highly potent alpha2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist

GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current

Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay

The orphan receptor GPR55 is a novel cannabinoid receptor

The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects

P304

422

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2017.00422

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Paula Morales

Nadine Jagerovic

P577

2017-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28701957

http://www.w3.org/2001/XMLSchema#string

P921

cannabidiol

cannabinoids

P932

5487438

http://www.w3.org/2001/XMLSchema#string

An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol.

about

P2860

P2860

An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932